Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miguel Álvarez-Rubio

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Clinical and Experimental Rheumatology|March 17, 2026
Giant cell arteritis and atherosclerosis: coexistence or causality?Miguel Ángel González-Gay, Ana De Benito-Vernière, Miguel Álvarez-Rubio, et al.
Clinical and Experimental Rheumatology|April 22, 2026
Coexistence of IgG4-related disease and PR3-ANCA-positive granulomatosis with polyangiitisMiguel Álvarez-Rubio, Mariam Belhaj-Gandar, Jaime Ángel Cáceres-Miranda, et al.
Expert Opinion on Pharmacotherapy|April 30, 2026
Targeted small molecules in Polymyalgia Rheumatica: the emerging role of jak inhibitors beyond glucocorticoids and DMARDsMiguel Ángel Gonzalez-Gay, Miguel Álvarez-Rubio, Ana de Benito-Vernière, et al.
Clinical and Experimental Rheumatology|April 9, 2025
Revisiting the epidemiology of giant cell arteritisMiguel Ángel González-Gay, Elena Heras-Recuero, Antia García-Fernández, et al.
Journal of Clinical Medicine|November 25, 2023
18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Findings of Polymyalgia Rheumatica in Patients with Giant Cell ArteritisElena Heras-Recuero, Marta Martínez de Bourio-Allona, Laura Cristina Landaeta-Kancev, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Clinical and Experimental Rheumatology|March 17, 2026
Giant cell arteritis and atherosclerosis: coexistence or causality?Miguel Ángel González-Gay, Ana De Benito-Vernière, Miguel Álvarez-Rubio, et al.
Clinical and Experimental Rheumatology|April 22, 2026
Coexistence of IgG4-related disease and PR3-ANCA-positive granulomatosis with polyangiitisMiguel Álvarez-Rubio, Mariam Belhaj-Gandar, Jaime Ángel Cáceres-Miranda, et al.
Expert Opinion on Pharmacotherapy|April 30, 2026
Targeted small molecules in Polymyalgia Rheumatica: the emerging role of jak inhibitors beyond glucocorticoids and DMARDsMiguel Ángel Gonzalez-Gay, Miguel Álvarez-Rubio, Ana de Benito-Vernière, et al.
Clinical and Experimental Rheumatology|April 9, 2025
Revisiting the epidemiology of giant cell arteritisMiguel Ángel González-Gay, Elena Heras-Recuero, Antia García-Fernández, et al.
Journal of Clinical Medicine|November 25, 2023
18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Findings of Polymyalgia Rheumatica in Patients with Giant Cell ArteritisElena Heras-Recuero, Marta Martínez de Bourio-Allona, Laura Cristina Landaeta-Kancev, et al.
Pageof 1